• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

When are I&I bold moves decision being handed down?













I&I is still working out placement this week. ZS really screwed up in some areas. Not sure if leadership looked at it before released.
Obviously not!
With people moving to other roles in company or leaving based on what territory they got, there are openings. My guess holding them for people in other BUs who get displaced to interview.